Transgenic mouse models of multiple sclerosis

被引:20
作者
Scheikl, Tanja [2 ,3 ]
Pignolet, Beatrice [2 ,3 ]
Mars, Lennart T. [2 ,3 ]
Liblau, Roland S. [1 ,2 ,3 ]
机构
[1] CHU Purpan, Ctr Physiopathol Toulouse Purpan, INSERM U563, F-31024 Toulouse 3, France
[2] Inst Natl Sante & Rech Med, Unite 563, Toulouse, France
[3] Univ Toulouse 3, F-31062 Toulouse, France
关键词
Transgenesis; Multiple sclerosis; EAE; CNS; T cells; Autoimmunity; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; CD8(+) T-CELLS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; VIRUS-INDUCED DEMYELINATION; NECROSIS-FACTOR-ALPHA; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MICE EXPRESSING INTERLEUKIN-6;
D O I
10.1007/s00018-010-0481-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Multiple sclerosis (MS) is an inflammatory demyelinating disease affecting the central nervous system (CNS) and a frequent cause of neurological disability in young adults. Multifocal inflammatory lesions in the CNS white matter, demyelination, oligodendrocyte loss, axonal damage, as well as astrogliosis represent the histological hallmarks of the disease. These pathological features of MS can be mimicked, at least in part, using animal models. This review discusses the current concepts of the immune effector mechanisms driving CNS demyelination in murine models. It highlights the fundamental contribution of transgenesis in identifying the mediators and mechanisms involved in the pathophysiology of MS models.
引用
收藏
页码:4011 / 4034
页数:24
相关论文
共 50 条
  • [21] An overall view of the most common experimental models for multiple sclerosis
    Dedoni, S.
    Scherma, M.
    Camoglio, C.
    Siddi, C.
    Dazzi, L.
    Puliga, R.
    Frau, J.
    Cocco, E.
    Fadda, P.
    NEUROBIOLOGY OF DISEASE, 2023, 184
  • [22] Cannabinoids and experimental models of multiple sclerosis
    Kubajewska, Ilona
    Constantinescu, Cris S.
    IMMUNOBIOLOGY, 2010, 215 (08) : 647 - 657
  • [23] In Vitro and In Vivo Models of Multiple Sclerosis
    van der Star, Baukje J.
    Vogel, Daphne Y. S.
    Kipp, Markus
    Puentes, Fabiola
    Baker, David
    Amor, Sandra
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (05) : 570 - 588
  • [24] Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis
    Chen, Bao Ying
    Salas, Jessica R.
    Trias, Alyssa O.
    Rodriguez, Arely Perez
    Tsang, Jonathan E.
    Guemes, Miriam
    Le, Thuc M.
    Galic, Zoran
    Shepard, H. Michael
    Steinman, Lawrence
    Nathanson, David A.
    Czernin, Johannes
    Witte, Owen N.
    Radu, Caius G.
    Schultz, Kenneth A.
    Clark, Peter M.
    IMMUNOLOGY, 2023, 168 (01) : 152 - 169
  • [25] The complexities of investigating mitochondria dynamics in multiple sclerosis and mouse models of MS
    Atkinson, Kelley C. C.
    Osunde, Marvellous
    Tiwari-Woodruff, Seema K. K.
    FRONTIERS IN NEUROSCIENCE, 2023, 17
  • [26] Viral mouse models used to study multiple sclerosis: past and present
    Libbey, J. E.
    Fujinami, R. S.
    ARCHIVES OF VIROLOGY, 2021, 166 (04) : 1015 - 1033
  • [27] Contribution of Intravital Neuroimaging to Study Animal Models of Multiple Sclerosis
    Buttigieg, Emeline
    Scheller, Anja
    El Waly, Bilal
    Kirchhoff, Frank
    Debarbieux, Franck
    NEUROTHERAPEUTICS, 2023, 20 (01) : 22 - 38
  • [28] Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
    Constantinescu, Cris S.
    Farooqi, Nasr
    O'Brien, Kate
    Gran, Bruno
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 164 (04) : 1079 - 1106
  • [29] Immune tolerance in multiple sclerosis
    Goverman, Joan M.
    IMMUNOLOGICAL REVIEWS, 2011, 241 : 228 - 240
  • [30] The cerebrospinal fluid immune cell landscape in animal models of multiple sclerosis
    Wu, Gregory F. F.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16